Literature DB >> 8135306

Risk factors for suicide in Huntingtons disease: a retrospective case controlled study.

H Lipe1, A Schultz, T D Bird.   

Abstract

We reviewed 11 instances of suicide in HD families to determine what clinical and social characteristics might alert health professionals to increased suicide potential. The subjects were eight males and one female affected with HD, one female at risk for HD, and one unaffected female spouse, ranging in age from 24 to 65 years. Six of the nine individuals with HD who committed suicide were single or divorced. Duration of HD symptoms ranged from 1 to 14 years. The single most important risk factor for suicide in HD was having no offspring. Other suicides in the family, being unmarried, having contact with others affected with HD, living alone, and depression slightly increased the risk of suicide. The suicide of an unaffected spouse and an individual at risk, but unaffected, emphasizes the heavy burden of HD on other family members. Recognition of these risk factors should allow health care providers to assist families coping with HD and presymptomatic diagnosis.

Entities:  

Mesh:

Year:  1993        PMID: 8135306     DOI: 10.1002/ajmg.1320480412

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  10 in total

Review 1.  Huntington's disease: a decade beyond gene discovery.

Authors:  Penelope Hogarth
Journal:  Curr Neurol Neurosci Rep       Date:  2003-07       Impact factor: 5.081

Review 2.  Cause or compensation?-Altered neuronal Ca2+ handling in Huntington's disease.

Authors:  James P Mackay; Wissam B Nassrallah; Lynn A Raymond
Journal:  CNS Neurosci Ther       Date:  2018-02-09       Impact factor: 5.243

Review 3.  Basal ganglia volumetric studies in affective disorder: what did we learn in the last 15 years?

Authors:  R M Bonelli; H-P Kapfhammer; S S Pillay; D A Yurgelun-Todd
Journal:  J Neural Transm (Vienna)       Date:  2005-10-27       Impact factor: 3.575

Review 4.  An overview of psychiatric symptoms in Huntington's disease.

Authors:  K E Anderson; K S Marder
Journal:  Curr Psychiatry Rep       Date:  2001-10       Impact factor: 5.285

5.  Suicidal behavior in prodromal Huntington disease.

Authors:  Jess G Fiedorowicz; James A Mills; Adam Ruggle; Douglas Langbehn; Jane S Paulsen
Journal:  Neurodegener Dis       Date:  2011-06-09       Impact factor: 2.977

Review 6.  Huntington's Disease-Update on Treatments.

Authors:  Kara J Wyant; Andrew J Ridder; Praveen Dayalu
Journal:  Curr Neurol Neurosci Rep       Date:  2017-04       Impact factor: 5.081

7.  Suicide in Neurologic Illness.

Authors:  David B. Arciniegas; C. Alan Anderson
Journal:  Curr Treat Options Neurol       Date:  2002-11       Impact factor: 3.598

8.  Perceived Effects of Neuropsychiatric Symptoms on Functional Status in Early-stage Huntington Disease.

Authors:  Jessie S Gibson; Bethany A Rhoten; Sheila H Ridner; Daniel O Claassen
Journal:  West J Nurs Res       Date:  2021-02-05       Impact factor: 1.774

9.  Risk factors for suicidality in Huntington disease: An analysis of the 2CARE clinical trial.

Authors:  Andrew McGarry; Michael P McDermott; Karl Kieburtz; Wai Lun Alan Fung; Elizabeth McCusker; Jing Peng; Elisabeth A de Blieck; Merit Cudkowicz
Journal:  Neurology       Date:  2019-03-08       Impact factor: 9.910

Review 10.  Huntingtin and Its Role in Mechanisms of RNA-Mediated Toxicity.

Authors:  Annika Heinz; Deepti Kailash Nabariya; Sybille Krauss
Journal:  Toxins (Basel)       Date:  2021-07-14       Impact factor: 4.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.